United States · FDA National Drug Code directory
TYVASO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 66302-206_78a0b514-481a-4ea9-8ec6-8b60acdf2158
- Product NDC
- 66302-206
- Form
- INHALANT
- Composition / generic term
- treprostinil
- Labeler
- United Therapeutics Corporation
- Marketing category
- NDA
- Marketing start / end (source format)
- 20090814
- Source listing expiry
- 20271231
Source-listed ingredients
- TREPROSTINIL — 1.74 mg/2.9mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOX in 1 KIT (66302-206-01) / 28 AMPULE in 1 BOX / 2.9 mL in 1 AMPULE · 66302-206-01
- 1 BOX in 1 KIT (66302-206-02) / 28 AMPULE in 1 BOX / 2.9 mL in 1 AMPULE · 66302-206-02
- 4 AMPULE in 1 BOX (66302-206-03) / 2.9 mL in 1 AMPULE · 66302-206-03
- 1 BOX in 1 KIT (66302-206-04) / 4 AMPULE in 1 BOX / 2.9 mL in 1 AMPULE · 66302-206-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →